The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis

By Swart Joost Frans   Barug Daantje   Möhlmann Michelle   Wulffraat Nico M  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 12, 2010-12 ,pp. : 1743-1752

Informa Healthcare

Access to resources Recommend Favorite

The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis

By Fleischmann Roy  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis

By Uhlenhake Elizabeth E   Feldman Steven R  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1105-1112

Informa Healthcare

Access to resources Recommend Favorite

Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety

By Beck Michael  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 255-261

Informa Healthcare

Access to resources Recommend Favorite

Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy

By Breccia Massimo   Lo-Coco Francesco  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 225-234

Informa Healthcare

Access to resources Recommend Favorite